Company Filing History:
Years Active: 2012
Title: Sadhana Jain: Innovator in Immunology
Introduction
Sadhana Jain is a prominent inventor based in West Roxbury, MA (US). She has made significant contributions to the field of immunology through her innovative research and development of binding proteins.
Latest Patents
Sadhana Jain holds a patent for "Methods of treatment utilizing binding proteins of the interleukin-21 receptor." This invention provides binding proteins and antigen-binding fragments that specifically target the human interleukin-21 receptor (IL-21R). The binding proteins can function as antagonists of IL-21R activity, thereby modulating immune responses. The disclosed compositions and methods have potential applications in diagnosing, treating, and preventing IL-21R-associated disorders, including inflammatory disorders, autoimmune diseases, allergies, and transplant rejection.
Career Highlights
Sadhana Jain is associated with Wyeth, a company known for its commitment to advancing healthcare through innovative solutions. Her work has been instrumental in developing therapies that address complex immune system disorders.
Collaborations
Sadhana has collaborated with notable colleagues, including Laird Bloom and Davinder Gill, to further her research and enhance the impact of her inventions.
Conclusion
Sadhana Jain's contributions to immunology through her patent on IL-21R binding proteins exemplify her dedication to advancing medical science. Her work continues to influence the development of treatments for various immune-related disorders.